ARS Pharmaceuticals (SPRY) Revenue (2020 - 2026)
ARS Pharmaceuticals (SPRY) revenue from Mar 31, 2020 to Mar 31, 2026. The TTM ARS Pharmaceuticals (SPRY) revenue is $99M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
ARS Pharmaceuticals (SPRY) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +1.93% |
| 3 Years TTM | +428.65% |
Annual Revenue change of ARS Pharmaceuticals (SPRY)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $23M | -73.09% |
| 2025 | $84M | -5.46% |
| 2024 | $89M | +297066.67% |
| 2023 | $30K | -97.73% |
| 2022 | $1.32M | -76.04% |
| 2021 | $5.51M | N/A |
| 2020 | $0 | N/A |